Clinical Trial Update: Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of insulin aspart in subjects with Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin aspart (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED